Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
Dingjiacheng Jia, Qiwen Wang, Yadong Qi, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1651-1665.e21
Closed Access | Times Cited: 98
Emerging roles of intratumor microbiota in cancer metastasis
Aikun Fu, Bingqing Yao, Tingting Dong, et al.
Trends in Cell Biology (2022) Vol. 33, Iss. 7, pp. 583-593
Closed Access | Times Cited: 70
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 47
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
Jiaao Sun, Feng Chen, Guangzhen Wu
The ISME Journal (2023) Vol. 17, Iss. 10, pp. 1535-1551
Open Access | Times Cited: 43
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Molecular crosstalk between polyphenols and gut microbiota in cancer prevention
Falak Zeb, Huma Naqeeb, Tareq M. Osaili, et al.
Nutrition Research (2024) Vol. 124, pp. 21-42
Closed Access | Times Cited: 17
Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer
Bowen Li, Zixian Wei, Zhiyue Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 220, pp. 125-138
Open Access | Times Cited: 17
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma
Mattia Ballerini, Serena Galié, Punit Tyagi, et al.
Nature Biomedical Engineering (2025)
Open Access | Times Cited: 2
Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers
Mi‐Young Son, Hyun‐Soo Cho
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 7, pp. 849-856
Open Access | Times Cited: 36
TGR5 deficiency-induced anxiety and depression-like behaviors: The role of gut microbiota dysbiosis
Yanlin Tao, Houyuan Zhou, Zikang Li, et al.
Journal of Affective Disorders (2023) Vol. 344, pp. 219-232
Closed Access | Times Cited: 27
T helper 17 (Th17) cell responses to the gut microbiota in human diseases
Chao‐Yue Sun, Na Yang, Zuo-Liang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114483-114483
Open Access | Times Cited: 25
Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l -Serine-Mediated NK Cell Activation
Nian Liu, Lihui Chen, Mingjie Yan, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 25
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 25
Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study
Ning Xie, Ziwei Wang, Qiuai Shu, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2937-2937
Open Access | Times Cited: 23
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Yinping Pan, Haojie Zhang, Minghui Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 11
The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy
Brian D. Griffith, Timothy L. Frankel
Cancers (2024) Vol. 16, Iss. 3, pp. 472-472
Open Access | Times Cited: 8
Rapid Biodistribution of Fluorescent Outer-Membrane Vesicles from the Intestine to Distant Organs via the Blood in Mice
Béatrice Schaack, Corinne Mercier, Maya Katby, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1821-1821
Open Access | Times Cited: 8
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 8
Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer
Cuijiao Feng, Na Li, Guangqi Gao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3768-3768
Open Access | Times Cited: 8
Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
Jinjing Zhang, Penghui Wang, Jiafeng Wang, et al.
Pharmacological Research (2024) Vol. 203, pp. 107185-107185
Open Access | Times Cited: 8
Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential
Roujie Huang, Zimo Liu, Tianshu Sun, et al.
Microbiological Research (2024) Vol. 287, pp. 127857-127857
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top